Comparison of ultrosound and contrast-enhanced CT in the diagnosis of cervical lymph nodes metastasis in patients with thyriod carcinoma: A meta-analysis
Li Hongwen, Xie Xinhui, Liu Bin, Wu Xingwang
Department of Radiology, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
Abstract:Objective To evaluate the clinical value of ultrasound (US) and contrast-enhanced CT(CECT) in the diagnosis of cervical lymph nodes metastasis in patients with thyroid carcinoma by a meta-analysis.Methods Literature search was performed in Medline, Embase, Cochrane, CBM datebases to identify relevant English and Chinese literatures with pathological result as the gold standard from January 1995 to December 2012. The quality of each selected study was evaluated by QUADAS. The Meta-disc 1.4 software was used to calculate the pooled sensitivity, specificity and the corresponding 95% CI. Summary receiver operating characteristic curves (ROC), area under curve (AUC) and the Q* index were calculated and used to evaluate the diagnostic efficiency of the two Methods by Z test.Results Totally seventeen literatures (1 682 patients) were included, the pooled sensitivity and specificity for and CECT scanning were 0.62, 0.61 and 0.92, 0.86. The AUC of the two were 0.84, 0.82 respectively. There was no statistically significant difference between US and CT (P=0.78) in the Q* index(0.7718, 0.7561).Conclusions US and CECT have similar value in the diagnosis of cervical lymph nodes metastasis in patients with thyroid carcinoma, but there is higher specificity in US than that in CECT.
李红文,谢新晖,刘斌,吴兴旺. 超声、增强CT诊断甲状腺癌颈部淋巴结转移比较的Meta分析[J]. 中华解剖与临床杂志, 2014, 19(5): 399-405.
Li Hongwen, Xie Xinhui, Liu Bin, Wu Xingwang. Comparison of ultrosound and contrast-enhanced CT in the diagnosis of cervical lymph nodes metastasis in patients with thyriod carcinoma: A meta-analysis. Chinese Journal of Anatomy and Clinics, 2014, 19(5): 399-405.
Esnaola NF, Cantor SB, Sherman SI, et al. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis[J]. Surgery, 2001, 130(6): 921-930.
[3]
The Cochrane Hand book for Systematic Reviews of Interventions[EB/OL]. http://www. cochrane. org/ resources/handbook/ Handbook4.pdf.
[4]
Shimamoto K, Satake H, Sawaki A, et al. Preoperative staging of thyroid papillary carcinoma with ultrasonography[J]. Eur J Radiol, 1998, 29(1): 4-10.
[5]
Kouvaraki MA, Shapiro SE, Fornage BD, et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer[J]. Surgery, 2003, 134(6): 946-954.
[6]
Jeong HS, Baek CH, Son YI, et al. Integrated 18F-FDG PET/CT for the initial evaluation of cervical node level of patients with papillary thyroid carcinoma: comparison with ultrasound and contrast-enhanced CT[J]. Clin Endocrinol, 2006, 65(3): 402-407.
[7]
Gonzalez HE, Cruz F, O′Brien A, et al. Impact of preoperative ultrasonographic staging of the neck in papillary thyroid carcinoma[J]. Arch Otolaryngol Head Neck Surg, 2007, 133(12): 1258-1262.
[8]
Ahn JE, Lee JH, Yi JS, et al. Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer[J]. World J Surg, 2008, 32(7): 1552-1558.
[9]
Kim E, Park JS, Son KR, et al. Preoperative diagnosis of cervical metastatic lymph nodes in papillary thyroid carcinoma: comparison of ultrasound, computed tomography, and combined ultrasound with computed tomography[J]. Thyroid, 2008, 18(4): 411-418.
[10]
Sugitani I, Fujimoto Y, Yamada K, et al. Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography[J]. World J Surg, 2008, 32(11): 2494-2502.
[11]
Choi JS, Kim J, Kwak JY, et al. Preoperative staging of papillary thyroid carcinoma: comparison of ultrasound imaging and CT[J]. AJR Am J Roentgenol, 2009, 193(3): 871-878.
[12]
Hwang HS, Perez DA, Orloff LA. Comparison of positron emission tomography/computed tomography imaging and ultrasound in staging and surveillance of head and neck and thyroid cancer[J]. Laryngoscope, 2009, 119(10): 1958-1965.
[13]
Roh JL, Park JY, Kim JM, et al. Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma[J]. J Surg Oncol, 2009, 99(1): 28-31.
[14]
Lee K, Kawata R, Nishikawa S, et al. Diagnostic criteria of ultrasonographic examination for lateral node metastasis of papillary thyroid carcinoma[J]. Acta Otolaryngol, 2010, 130(1): 161-166.
[15]
Morita S, Mizoguchi K, Suzuki M, et al. The accuracy of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography, ultrasonography, and enhanced computed tomography alone in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma[J]. World J Surg, 2010, 34(11): 2564-2569.
[16]
Yoon JH, Kim JY, Moon HJ, et al. Contribution of computed tomography to ultrasound in predicting lateral lymph node metastasis in patients with papillary thyroid carcinoma[J]. Ann Surg Oncol, 2011, 18(6): 1734-1741.
[17]
Seo YL, Yoon DY, Baek S, et al. Detection of neck recurrence in patients with differentiated thyroid cancer: comparison of ultrasound, contrast-enhanced CT and 18F-FDG PET/CT using surgical pathology as a reference standard: (ultrasound vs. CT vs. 18F-FDG PET/CT in recurrent thyroid cancer) [J]. Eur Radiol, 2012, 22(10): 2246-2254.
[18]
Lee DW, Ji YB, Sung ES, et al. Roles of ultrasonography and computed tomography in the surgical management of cervical lymph node metastases in papillary thyroid carcinoma[J]. Eur J SurgOncol, 2013, 39(2): 191-196.
Lee DH, Kang WJ, Seo HS, et al. Detection of metastatic cervical lymph nodes in recurrent papillary thyroid carcinoma: computed tomography versus positron emission tomography-computed tomography[J]. J Comput Assist Tomogr, 2009, 33(5): 805-810.
[21]
Watkinson JC, Franklyn JA, Olliff JF. Detection and surgical treatment of cervical lymph nodes in differentiated thyroid cancer[J]. Thyroid, 2006, 16(2): 187-194.
[22]
van den Brekel MW. Lymph node metastases: CT and MRI[J]. Eur J Radiol, 2000, 33(3): 230-238.
[23]
Wu LM, Gu HY, Qu XH, et al. The accuracy of ultrasonography in the preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: A meta-analysis[J]. Eur J Radiol, 2012, 81(8): 1798-1805.
[24]
Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests[J]. BMJ, 2001, 323(7305): 157-162.
[25]
Vassallo P, Wernecke K, Roos N, et al. Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US[J]. Radiology, 1992, 183(1): 215-220.
[26]
Rosario PW, de Faria S, Bicalho L, et al. Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma[J]. J Ultrasound Med, 2005, 24(10): 1385-1389.
[27]
Kuna SK, Bracic I, Tesic V, et al. Ultrasonographic differentiation of benign from malignant neck lymphadenopathy in thyroid cancer[J]. J Ultrasound Med, 2006, 25(12): 1531-1537.
[28]
Som PM, Brandwein M, Lidov M, et al. The varied presentations of papillary thyroid carcinoma cervical nodal disease: CT and MR findings[J]. AJNR Am J Neuroradiol, 1994, 15(6): 1123-1128.
[29]
Bobbins KT, Clayman G, Levine PA, et a1. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery[J]. Arch Otolaryngol Head Neck Surg, 2002, 128(7): 751-758.
[30]
Sivanandan R, Soo KC. Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid[J]. Br J Surg, 2001, 88(9): 1241-1244.
[31]
European Society of Urogenital Radiology 2007 ESUR guidelines on contrast media, version 6.0[EB/OL] http//www.esur.org/fileadmin/Guidelines/ESUR_2007_Guideline_6_Kern_Ubersicht.pdf.